ENLIVEX THERAPEUTICS LTD's ticker is ENLV and the CUSIP is M4130Y106. A total of 27 filers reported holding ENLIVEX THERAPEUTICS LTD in Q4 2021. The put-call ratio across all filers is 1.59 and the average weighting 0.0%.
Quarter-by-quarter ownership
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Susquehanna International Group Ltd. | 12,326 | $19,475 | 0.01% |
| Compagnie Lombard Odier SCmA | 65,000 | $104,082 | 0.00% |
| OSAIC HOLDINGS, INC. | 400 | $632 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 838 | $1,324 | 0.00% |
| WELLS FARGO & COMPANY/MN | 8,882 | $14,034 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 10,420 | $16,463 | 0.00% |
| MORGAN STANLEY | 44,156 | $69,766 | 0.00% |
| Citadel Advisors | 1,500 | $2,370 | 0.00% |
| Citadel Advisors | 4,900 | $7,742 | 0.00% |